A multicenter pilot study of a bronchial valve for the treatment of severe emphysema

Respiration

Volumn 79, Issue 3, 2010, Pages 222-233

  Sterman, D H ^a   Mehta, A C ^b   Wood, D E ^c   Mathur, P N ^d   McKenna Jr , R J ^e   Ost, D E ^f   Truwit, J D ^g   Diaz, P ^h   Wahidi, M M ⁱ   Cerfolio, R ^j   Maxfield, R ^k   Musani, A I ^a   Gildea, T ^b   Sheski, F ^c   MacHuzak, M ^a,b   Haas, A R ^a   Gonzalez, H X ^l   Springmeyer, S C ^l  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d INDIANA UNIVERSITY   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k NewYork Presbyterian Hospital   (United States)

^l Spiration Inc   (United States)

more..

Author keywords

Bronchial valve; Bronchoscopic treatment of emphysema; Chronic obstructive pulmonary disease; Emphysema; Endobronchial lung volume reduction; Valve placement

Indexed keywords

OXYGEN;

ADULT; AGED; ARTERIAL GAS; ARTICLE; BREATHING; BRONCHIAL VALVE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE SEVERITY; EMPHYSEMA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TOTAL LUNG CAPACITY; VALVE;

ADULT; AGED; BLOOD GAS ANALYSIS; BRONCHOSCOPY; DEVICE REMOVAL; EXERCISE TEST; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; OXYGEN; PILOT PROJECTS; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; PULMONARY CIRCULATION; PULMONARY EMPHYSEMA; QUALITY OF LIFE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNITED STATES;

EID: 76749171135     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000259318     Document Type: Article

References (41)

1. Mannino DM, Buist AS: Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007: 370: 765-773.
2. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbol J: Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799-805.
3. Celli BR: Update on management of COPD. Chest 2008; 133: 1451-1462.
4. Make BJ, Martinez FJ: Assessment of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 884-890.
5. National Emphysema Treatment Trial Research Group: A randomized trial comparing lung volume reduction with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073.
6. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, Fishman AP: Long-term followup of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006; 82: 431-443.
7. Naunheim KS, Wood DE, Krasna MJ, De-Camp MM Jr, Ginsburg ME, McKenna RJ, Criner GJ, Hoffman E, Sternberg AL, Deschamps C, for the National Emphysema Treatment Trial Research Group: Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006; 131: 43-53.
8. Naunheim K: Lung-volume reduction surgery: a vanishing operation? J Thorac Cardiovasc Surg 2007; 133: 1412-1413.
9. Sabanathan S, Richardson J, Pieri-Davis S: Bronchoscopic lung volume reduction. J Cardiovasc Surg (Torino) 2003; 44: 101-108.
10. Toma TP, Hopkinson NS, Hillier J, Hansell DM, Morgan C, Goldstraw PG, et al: Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003: 361: 931-933.
11. Snell GI, Holsworth L, Borrill ZL, Thomson KR, Kalff V, Smith JA, Williams TJ: The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124: 1073-1080.
12. Ingenito EP, Berger RL, Henderson AC, Reilly JJ, Larry Tsai L, Hoffman A: Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med 2003; 167: 771-778.
13. Rendina EA, De Giacomo T, Venuta F, Coloni GF, Meyers BF, Patterson GA, Cooper JD: Feasibility and safety of the airway bypass procedure for patients with emphysema. J Thorac Cardiovasc Surg 2003; 125: 1294-1299.
14. FDA News: FDA Approves Lung Valve to Control Some Air Leaks after Surgery (cited June 26, 2009). http://www.fda.gov/News Event s /Newsroom/Pres sAnnouncements/ 2008/ucm116970.htm
15. Wood DE, McKenna RJ Jr, Yusen RD, Sterman DH, Ost DE, Springmeyer SC, et al: A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133: 65-73.
16. Springmeyer SC, Bolliger CT, Waddell TK, Gonzalez X, Wood DE: Treatment of heterogeneous emphysema using the Spiration IBV valves. Thorac Surg Clin 2009; 19: 247-253.
17. Coxson HO, Nasute Fauerbach PV, Storness-Bliss C, Muller NL, Cogswell S, Dillard DH, et al: The computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J 2008; 32: 1443-1450.
18. Gelb AF, Gutierrez CA, Weisman IM, Newsom R, Taylor CF, Zamel N: Simplified detection of dynamic hyperinflation. Chest 2004; 126: 1855-1860.
19. National Emphysema Treatment Trial Research Group: Rationale and design of the National Emphysema Treatment Trial. A prospective randomized trial of lung volume reduction surgery. Chest 1999; 116: 1750-1761.
20. Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404.
21. Jones PW: Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
22. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, et al: Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171: 453-460.
23. Krowka MJ, Enright PL, Rodarte JR, Hyatt RE: Effect of effort on measurement of forced expiratory volume in one second. Am Rev Respir Dis 1987; 136: 829-833.
24. Suratt PM, Hooe DM, Owens DA, Anne A: Effect of maximal versus submaximal expiratory effort on spirometric values. Respiration 1981; 42: 233-236.
25. Nici L, ZuWallack R, Wouters E, Donner CF: On pulmonary rehabilitation and the flight of the bumblebee: the ATS/ERS Statement on Pulmonary Rehabilitation. Eur Respir J 2006; 28: 461-462. (Pubitemid 44794655)
26. O'Donnell DE, Lam M, Webb KA: Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-549.
27. Nishimura K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
28. Reilly J: COPD and declining FEV 1 -time to divide and conquer? N Engl J Med 2008; 359: 1616-1618.
29. Casanova C, Cote CG, Marin JM, de Torres JP, Aguirre-Jaime A, Mendez R, et al: The six-minute walk test: long-term follow up in patients with COPD. Eur Respir J 2007; 29: 535-540.
30. Wise RA, Brown CD: Minimally clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD 2005; 2: 125-129.
31. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861. (Pubitemid 30004687)
32. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
33. Chetta A, Pisi G, Aiello M, Tzani P, Olivieri D: The walking capacity assessment in the respiratory patient. Respiration 2009; 77: 361-367.
34. Ingle L, Rigby AS, Nabb S, Jones PK, Clark AL, Cleland JG: Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 2006; 8: 321-325.
35. Colt HG, Matsuo T: Hospital charges attributable to bronchoscopy-related complications in outpatients. Respiration 2001; 68: 67-72.
36. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MD, Deloney PA, Sundaresan RS, Roper CL: Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-116.
37. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
38. Washko GR, Fan VS, Ramsey SD, Mohsenifar Z, Martinez F, Make BJ, Sciurba FC, Criner GJ, Minai O, Decamp MM, et al: The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 177: 164-169.
39. Wan IYP, Toma TP, Geddes DM, et al: Bronchoscopic lung volume reduction for endstage emphysema. Chest 2006; 129: 518-526.
40. Strange C, Herth FJF, Kovitz KL, et al: Design of the endobronchial valve for emphysema palliation trial (VENT): a nonsurgical method of lung volume reduction. BMC Pulm Med 2007; 7: 10.
41. Pulmonx: Clinical information: VENT Study. http://www.pulmonx.com/ clinicalinformation/ vent-study/index.html.